Completed PHASE3 INTERVENTIONAL 2-arm NCT00389233

A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution

A Randomised, Multi-Centre, Single-Blinded, Pivotal Phase III Trial to Assess the Efficacy, Acceptability and Safety of a New 2 Litre Gut Cleansing Solution NRL994 Versus a Standard Colon Preparation With 4L PEG+E.

Sponsor: Norgine

Conditions Colonoscopy

Interventions Macrogol3350 NA sulphate NACl KCl ascorbic acid NA ascorbate Macrogol3350 Na sulphate Na bicarbonate NaCl KCl

Updated 6 times since 2017 Last updated: Apr 15, 2008 Started: Jun 30, 2002 Completion: Dec 31, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Colonoscopy, this trial is completed. The trial is conducted by Norgine and has accumulated 6 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jun 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Norgine

Data source: Norgine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amberg, Germany , Aschaffenburg, Germany , Dachau, Germany , Erfurt, Germany , Erlangen, Germany , Essen, Germany , Frankfurt am Main, Germany , Fürth, Germany , Hamburg, Germany , Tirschenreuth, Germany and 1 more location